• Product name
    Anti-IL27 antibody [B-G49] (FITC)
    See all IL27 primary antibodies
  • Description
    Mouse monoclonal [B-G49] to IL27 (FITC)
  • Conjugation
    FITC. Ex: 493nm, Em: 528nm
  • Specificity
    Recognizes both natural and recombinant IL27.
  • Tested applications
    Suitable for: Flow Cytmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant Human IL27

  • Positive control
    • Dendritic cells.



Our Abpromise guarantee covers the use of ab84472 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Flow Cyt
  • Application notes
    Flow Cyt: Use 10µl for 106 cells or 100 µl of whole blood.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Function
      Cytokine with pro- and anti-inflammatory properties, that can regulate T helper cell development, suppress T-cell proliferation, stimulate cytotoxic T cell activity, induce isotype switching in B-cells, and that has diverse effects on innate immune cells. Among its target cells are CD4 T helper cells which can differentiate in type 1 effector cells (TH1), type 2 effector cells (TH2) and IL17 producing helper T-cells (TH17). It drives rapid clonal expansion of naive but not memory CD4 T-cells. It also strongly synergizes with IL-12 to trigger interferon-gamma/IFN-gamma production of naive CD4 T-cells, binds to the cytokine receptor WSX-1/TCCR which appears to be required but not sufficient for IL-27-mediated signal transduction. IL-27 potentiate the early phase of TH1 response and suppress TH2 and TH17 differentiation. It induces the differentiation of TH1 cells via two distinct pathways, p38 MAPK/TBX21- and ICAM1/ITGAL/ERK-dependent pathways. It also induces STAT1, STAT3, STAT4 and STAT5 phosphorylation and activates TBX21/T-Bet via STAT1 with resulting IL12RB2 up-regulation, an event crucial to TH1 cell commitment. It suppresses the expression of GATA3, the inhibitor TH1 cells development. In CD8 T-cells, it activates STATs as well as GZMB. IL-27 reveals to be a potent inhibitor of TH17 cell development and of IL-17 production. Indeed IL-27 subunit p28 alone is also able to inhibit the production of IL17 by CD4 and CD8 T-cells. While IL-27 suppressed the development of proinflammatory Th17 cells via STAT1, it inhibits the development of anti-inflammatory inducible regulatory T-cells, iTreg, independently of STAT1. IL-27 has also an effect on cytokine production, it suppresses proinflammatory cytokine production such as IL2, IL4, IL5 and IL6 and activates suppressors of cytokine signaling such as SOCS1 and SOCS3. Apart from suppression of cytokine production, IL-27 also antagonizes the effects of some cytokines such as IL6 through direct effects on T cells. Another important role of IL-27 is its antitumor activity as well as its antiangiogenic activity with activation of production of antiangiogenic chemokines such as IP-10/CXCL10 and MIG/CXCL9. In vein endothelial cells, it induces IRF1/interferon regulatory factor 1 and increase the expression of MHC class II transactivator/CIITA with resulting up-regulation of major histocompatibility complex class II. IL-27 also demonstrates antiviral activity with inhibitory properties on HIV-1 replivation.
    • Tissue specificity
      Expressed in monocytes and in placenta.
    • Sequence similarities
      Belongs to the IL-6 superfamily.
    • Post-translational
    • Cellular localization
      Secreted. Does not seem to be secreted without coexpression of EBI3.
    • Information by UniProt
    • Database links
    • Alternative names
      • EBI3 antibody
      • IL 27 antibody
      • IL 27 p28 subunit antibody
      • IL 27A antibody
      • IL 30 antibody
      • IL-27 subunit alpha antibody
      • IL-27-A antibody
      • IL27 antibody
      • IL27-A antibody
      • IL27A antibody
      • IL27A_HUMAN antibody
      • IL27p28 antibody
      • IL30 antibody
      • Interleukin 27 antibody
      • Interleukin 27 subunit alpha antibody
      • Interleukin 27, 28-KD subunit antibody
      • Interleukin 30 antibody
      • Interleukin-27 subunit alpha antibody
      • p28 antibody
      see all

    Anti-IL27 antibody [B-G49] (FITC) images

    • Dendritic cells were activated with LPS 1µg/ml, IFN gamma 10ng/ml and TNF-alpha 100ng/ml for 48hours. Unactivated dendritic cells were used as negative control. 3.1 x 105 dendritic cells (activated = green line or resting cells = black line) were labelled with 10µl of ab84472.

    References for Anti-IL27 antibody [B-G49] (FITC) (ab84472)

    ab84472 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab84472.
    Please use the links above to contact us or submit feedback about this product.


    Sign up